{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:49:15Z","timestamp":1761662955384},"reference-count":84,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1097\/ta.0b013e3181f2d4fb","type":"journal-article","created":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T07:10:02Z","timestamp":1297321802000},"page":"498-506","source":"Crossref","is-referenced-by-count":21,"title":["Candidemia in Burn Patients: Figures and Facts"],"prefix":"10.1097","volume":"70","author":[{"given":"Ana Filipa Bastos","family":"Pedrosa","sequence":"first","affiliation":[]},{"given":"Ac\u00e1cio Gon\u00e7alves","family":"Rodrigues","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-38-20210211","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.burns.2008.04.007","article-title":"Incidence of systemic fungal infection and related mortality following severe burns.","volume":"34","author":"Murray","year":"2008","journal-title":"Burns"},{"key":"R2-38-20210211","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.burns.2008.02.010","article-title":"Mortality and causes of death in a burn centre.","volume":"34","author":"Bloemsma","year":"2008","journal-title":"Burns"},{"key":"R3-38-20210211","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.burns.2006.01.012","article-title":"Delayed death in burns and the allegations of medical negligence.","volume":"32","author":"Sharma","year":"2006","journal-title":"Burns"},{"key":"R4-38-20210211","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.burns.2006.09.002","article-title":"Septicemia as a cause of death in burns.","volume":"33","author":"Vandijck","year":"2007","journal-title":"Burns"},{"key":"R5-38-20210211","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/BCR.0b013e31815f6ecb","article-title":"Positive fungal cultures in burn patients: a multicenter review.","volume":"29","author":"Ballard","year":"2008","journal-title":"J Burn Care Res"},{"key":"R6-38-20210211","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/archsurg.1988.01400260078009","article-title":"Candida. A decreasing problem for the burned patient?","volume":"123","author":"Grube","year":"1988","journal-title":"Arch Surg"},{"key":"R7-38-20210211","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/321811","article-title":"Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey.","volume":"33","author":"Blumberg","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R8-38-20210211","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R9-38-20210211","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s15010-005-5066-4","article-title":"Antibiotic-resistant bloodstream infections in hospitalized patients: specific risk factors in a high-risk population?","volume":"33","author":"von Baum","year":"2005","journal-title":"Infection"},{"key":"R10-38-20210211","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R11-38-20210211","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/520192","article-title":"Nosocomial bloodstream infections in United States hospitals: a three-year analysis.","volume":"29","author":"Edmond","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R12-38-20210211","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","article-title":"Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003.","volume":"43","author":"Almirante","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R13-38-20210211","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1086\/342300","article-title":"Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989\u20131999.","volume":"35","author":"Trick","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R14-38-20210211","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/380637","article-title":"Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991\u20132000.","volume":"38","author":"Marchetti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R15-38-20210211","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10096-007-0448-4","article-title":"A first Portuguese epidemiological survey of fungaemia in a university hospital.","volume":"27","author":"Costa-de-Oliveira","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R16-38-20210211","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1128\/JCM.39.9.3254-3259.2001","article-title":"International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.","volume":"39","author":"Pfaller","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R17-38-20210211","first-page":"493","article-title":"Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992\u20131994. Fungal Disease Registry of the Canadian Infectious Disease Society.","volume":"160","author":"Yamamura","year":"1999","journal-title":"CMAJ"},{"key":"R18-38-20210211","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s10096-003-0890-x","article-title":"Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality.","volume":"22","author":"Alonso-Valle","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R19-38-20210211","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/jhin.2001.1151","article-title":"Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.","volume":"50","author":"Krcmery","year":"2002","journal-title":"J Hosp Infect"},{"key":"R20-38-20210211","first-page":"213","article-title":"A ten-year review of Candida sepsis and mortality in burn patients.","volume":"101","author":"Prasad","year":"1987","journal-title":"Surgery"},{"key":"R21-38-20210211","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0305-4179(95)00069-N","article-title":"Management of Candida septicaemia in a regional burn unit.","volume":"21","author":"Still","year":"1995","journal-title":"Burns"},{"key":"R22-38-20210211","first-page":"447","article-title":"Treatment options of invasive fungal infections in adults.","volume":"136","author":"Fl\u00fcckiger","year":"2006","journal-title":"Swiss Med Wkly"},{"key":"R23-38-20210211","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1099\/jmm.0.46548-0","article-title":"Invasive fungal infections: a review of epidemiology and management options.","volume":"55","author":"Enoch","year":"2006","journal-title":"J Med Microbiol"},{"key":"R24-38-20210211","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/AAC.44.3.747-751.2000","article-title":"Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997\u20131998.","volume":"44","author":"Pfaller","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R26-38-20210211","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0002-9610(97)89647-X","article-title":"Fungal infection in surgical patients.","volume":"171","author":"Dean","year":"1996","journal-title":"Am J Surg"},{"key":"R27-38-20210211","first-page":"8","article-title":"Propofol lipidic infusion promotes resistance to antifungals by reducing drug input into the fungal cell.","volume":"17","author":"Costa-de-Oliveira","year":"2008","journal-title":"BMC Microbiol"},{"key":"R28-38-20210211","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/13693780500129814","article-title":"Human albumin promotes germination, hyphal growth and antifungal resistance by Aspergillus fumigatus.","volume":"43","author":"Rodrigues","year":"2005","journal-title":"Med Mycol"},{"key":"R29-38-20210211","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2334-5-22","article-title":"Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species.","volume":"5","author":"Cheng","year":"2005","journal-title":"BMC Infect Dis"},{"key":"R30-38-20210211","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijid.2006.03.003","article-title":"Distribution and epidemiology of Candida species causing funguemia at a Saudi Arabian hospital, 1996\u20132004.","volume":"11","author":"Al-Tawfiq","year":"2007","journal-title":"Int J Infect Dis"},{"key":"R31-38-20210211","first-page":"269","article-title":"Focus on risk factors for fungal infections in ICU patients.","volume":"68","author":"Tufano","year":"2002","journal-title":"Minerva Anestesiol"},{"key":"R32-38-20210211","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1128\/CMR.19.2.403-434.2006","article-title":"Burn wound infections.","volume":"19","author":"Church","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"R33-38-20210211","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00000658-197707000-00012","article-title":"Changes in humoral components of host defense following burn trauma.","volume":"186","author":"Bjornson","year":"1977","journal-title":"Ann Surg"},{"key":"R34-38-20210211","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7150\/ijbs.3.393","article-title":"Thermal injury-plus-sepsis contributes to a substantial deletion of intestinal mesenteric lymph node CD4 T cell via apoptosis.","volume":"3","author":"Fazal","year":"2007","journal-title":"Int J Biol Sci"},{"key":"R35-38-20210211","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1086\/323759","article-title":"Revisiting the source of candidemia: skin or gut?","volume":"33","author":"Nucci","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R36-38-20210211","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0140-6736(69)91534-7","article-title":"Fungaemia and funguria after oral administration of Candida albicans.","volume":"1","author":"Krause","year":"1969","journal-title":"Lancet"},{"key":"R37-38-20210211","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.burns.2007.03.010","article-title":"Early enteral feeding for burned patients\u2014an effective method which should be encouraged in developing countries.","volume":"34","author":"Lam","year":"2008","journal-title":"Burns"},{"key":"R38-38-20210211","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0732-8893(99)00035-8","article-title":"Nosocomial fungal infections: candidemia.","volume":"34","author":"Verduyn Lunel","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R39-38-20210211","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004630-199507000-00011","article-title":"Candidemia in the pediatric patient with burns.","volume":"16","author":"Sheridan","year":"1995","journal-title":"J Burn Care Rehabil"},{"key":"R40-38-20210211","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.burns.2008.01.014","article-title":"Comparison of WBC, ESR, CRP and PCT serum levels in septic and non-septic burn cases.","volume":"34","author":"Barati","year":"2008","journal-title":"Burns"},{"key":"R41-38-20210211","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/BCR.0b013e3181599bc9","article-title":"American Burn Association consensus conference to define sepsis and infection in burns.","volume":"28","author":"Greenhalgh","year":"2007","journal-title":"J Burn Care Res"},{"key":"R42-38-20210211","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0305-4179(98)00109-0","article-title":"Procalcitonin\u2014a sepsis parameter in severe burn injuries.","volume":"24","author":"von Heimburg","year":"1998","journal-title":"Burns"},{"key":"R43-38-20210211","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.burns.2006.10.401","article-title":"Evaluation of serum procalcitonin concentration in the ICU following severe burn.","volume":"33","author":"Bargues","year":"2007","journal-title":"Burns"},{"key":"R44-38-20210211","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/13693780701501787","article-title":"Multiplex PCR identification of eight clinically relevant Candida species.","volume":"45","author":"Carvalho","year":"2007","journal-title":"Med Mycol"},{"key":"R45-38-20210211","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/JCM.31.4.865-871.1993","article-title":"Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC Plus 26 aerobic blood culture bottle, and 10-milliliter isolator blood culture system for detection of fungemia and bacteremia.","volume":"31","author":"Wilson","year":"1993","journal-title":"J Clin Microbiol"},{"key":"R46-38-20210211","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1525-1578(10)60498-9","article-title":"Early detection and identification of commonly encountered Candida species from simulated blood cultures by using a real-time PCR-based assay.","volume":"6","author":"Maaroufi","year":"2004","journal-title":"J Mol Diagn"},{"key":"R47-38-20210211","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1128\/JCM.38.4.1439-1443.2000","article-title":"A rapid, automated enzymatic fluorometric assay for determination of D-arabinitol in serum.","volume":"38","author":"Yeo","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R48-38-20210211","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0002-9343(99)80136-3","article-title":"Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol.","volume":"99","author":"Walsh","year":"1995","journal-title":"Am J Med"},{"key":"R49-38-20210211","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1\u2013>3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.","volume":"41","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R50-38-20210211","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/CDLI.10.5.882-885.2003","article-title":"Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients.","volume":"10","author":"Digby","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"R51-38-20210211","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1002\/pmic.200400903","article-title":"Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies.","volume":"4","author":"Pitarch","year":"2004","journal-title":"Proteomics"},{"key":"R52-38-20210211","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s10096-005-0041-7","article-title":"Diagnosis of candidemia by polymerase chain reaction and blood culture: prospective study in a high-risk population and identification of variables associated with development of candidemia.","volume":"24","author":"Moreira-Oliveira","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R53-38-20210211","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1128\/JCM.42.7.3159-3163.2004","article-title":"Comparison of different methods of isolation of DNA of commonly encountered Candida species and its quantitation by using a real-time PCR-based assay.","volume":"42","author":"Maaroufi","year":"2004","journal-title":"J Clin Microbiol"},{"key":"R54-38-20210211","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1128\/JCM.01556-06","article-title":"Multiplex real-time PCR targeting the RNAse P RNA gene for detection and identification of Candida species in blood.","volume":"45","author":"Innings","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R55-38-20210211","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1473-3099(03)00580-2","article-title":"British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.","volume":"3","author":"Denning","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"R56-38-20210211","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","article-title":"Candida colonization and subsequent infections in critically ill surgical patients.","volume":"220","author":"Pittet","year":"1994","journal-title":"Ann Surg"},{"key":"R57-38-20210211","first-page":"604","article-title":"Intensive Care Medicine. Annual Update 2006.","author":"Eggimann","year":"2006"},{"key":"R58-38-20210211","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis.","volume":"38","author":"Pappas","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R59-38-20210211","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s15010-006-5677-4","article-title":"Comparison of risk factors for candidemia versus bacteremia in hospitalized patients.","volume":"34","author":"Amrutkar","year":"2006","journal-title":"Infection"},{"key":"R60-38-20210211","first-page":"48","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.","volume":"1","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R61-38-20210211","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1086\/499057","article-title":"Current treatment strategies for disseminated candidiasis.","volume":"42","author":"Spellberg","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R62-38-20210211","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R63-38-20210211","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10096-007-0383-4","article-title":"Use of the PATH Alliance database to measure adherence to IDSA guidelines for the therapy of candidemia.","volume":"26","author":"Horn","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R64-38-20210211","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.","volume":"331","author":"Rex","year":"1994","journal-title":"N Engl J Med"},{"key":"R65-38-20210211","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF01726360","article-title":"Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group.","volume":"16","author":"Phillips","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R66-38-20210211","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1086\/514504","article-title":"International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.","volume":"25","author":"Edwards","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R67-38-20210211","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1128\/JCM.41.4.1440-1446.2003","article-title":"Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.","volume":"41","author":"Pfaller","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R68-38-20210211","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1439-0507.2008.01645.x","article-title":"Treatment of invasive candidiasis with echinocandins.","volume":"52","author":"Gl\u00f6ckner","year":"2009","journal-title":"Mycoses"},{"key":"R69-38-20210211","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis.","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"R70-38-20210211","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJMct060052","article-title":"Echinocandins for candidemia in adults without neutropenia.","volume":"355","author":"Bennett","year":"2006","journal-title":"N Engl J Med"},{"key":"R71-38-20210211","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1469-0691.2008.02660.x","article-title":"Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.","volume":"15","author":"Ghannoum","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"R72-38-20210211","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1128\/JCM.00409-07","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.","volume":"45","author":"Pfaller","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R73-38-20210211","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1369-5274(02)00344-2","article-title":"Resistance of human fungal pathogens to antifungal drugs.","volume":"5","author":"Sanglard","year":"2002","journal-title":"Curr Opin Microbiol"},{"key":"R74-38-20210211","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1086\/344651","article-title":"Candida lusitaniae infections in the era of fluconazole availability.","volume":"36","author":"Hawkins","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R75-38-20210211","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1128\/AAC.42.10.2645","article-title":"Mechanism of fluconazole resistance in Candida krusei.","volume":"42","author":"Orozco","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"R76-38-20210211","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/JCM.44.5.1740-1743.2006","article-title":"Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.","volume":"44","author":"Panackal","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R77-38-20210211","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.","volume":"118","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"key":"R78-38-20210211","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.amjmed.2003.07.005","article-title":"Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.","volume":"115","author":"Harbarth","year":"2003","journal-title":"Am J Med"},{"key":"R79-38-20210211","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.burns.2005.09.005","article-title":"Meta-analysis of early excision of burns.","volume":"32","author":"Ong","year":"2006","journal-title":"Burns"},{"key":"R80-38-20210211","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0305-4179(00)00061-9","article-title":"An open study comparing topical silver sulfadiazine and topical silver sulfadiazine-cerium nitrate in the treatment of moderate and severe burns.","volume":"27","author":"de Gracia","year":"2001","journal-title":"Burns"},{"key":"R81-38-20210211","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.burns.2005.01.014","article-title":"Cerium nitrate in the management of burns.","volume":"31","author":"Garner","year":"2005","journal-title":"Burns"},{"key":"R82-38-20210211","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0305-4179(01)00038-9","article-title":"Treatment with cerium nitrate bathing modulates systemic leukocyte activation following burn injury: an experimental study in rat cremaster muscle flap.","volume":"27","author":"Eski","year":"2001","journal-title":"Burns"},{"key":"R83-38-20210211","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/01.CCM.0000208357.05675.C3","article-title":"Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials.","volume":"34","author":"Vardakas","year":"2006","journal-title":"Crit Care Med"},{"key":"R84-38-20210211","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/cc6191","article-title":"Single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients: a systematic review.","volume":"11","author":"van Till","year":"2007","journal-title":"Crit Care"},{"key":"R85-38-20210211","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1128\/CMR.00059-05","article-title":"Human pharmacogenomic variations and their implications for antifungal efficacy.","volume":"19","author":"Meletiadis","year":"2006","journal-title":"Clin Microbiol Rev"}],"container-title":["Journal of Trauma: Injury, Infection & Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0b013e3181f2d4fb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:14:43Z","timestamp":1620976483000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005373-201102000-00038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0b013e3181f2d4fb","relation":{},"ISSN":["0022-5282"],"issn-type":[{"value":"0022-5282","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}